BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/23/2023 8:29:43 AM | Browse: 262 | Download: 662
 |
Received |
|
2022-12-26 13:10 |
|
Peer-Review Started |
|
2022-12-26 13:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-01-06 17:50 |
|
Revised |
|
2023-01-19 04:25 |
|
Second Decision |
|
2023-02-24 04:10 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-02-28 02:52 |
|
Articles in Press |
|
2023-02-28 02:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-20 01:52 |
|
Publish the Manuscript Online |
|
2023-03-23 08:29 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Review |
| Article Title |
Immunomodulation: The next target of mesenchymal stem cell-derived exosomes in the context of ischemic stroke
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xiao-Qian Shan, Yong-Yin Luo, Jun Chang, Jing-Jing Song, Nan Hao and Lan Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82074533 |
|
| Corresponding Author |
Lan Zhao, PhD, Research Fellow, NA, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, No. 88 Chang Ling Road, Xi Qing District, Tianjin 300381, China. lanzhao69@163.com |
| Key Words |
Mesenchymal stem cells; Exosomes; Ischemic stroke; Immunomodulation; Inflammation; Exosome therapy |
| Core Tip |
Mesenchymal stem cell-derived exosomes (MSC-Exos) are an emerging strategy for treating ischemic stroke (IS) and have demonstrated certain achievements in animal studies. Here, we review and discuss the mechanisms of MSC-Exos in treating IS through immunomodulation, the current responses to the clinical limitations of MSC-Exos therapy, and the issues that need to be addressed in future MSC-Exos research. |
| Publish Date |
2023-03-23 08:29 |
| Citation |
Shan XQ, Luo YY, Chang J, Song JJ, Hao N, Zhao L. Immunomodulation: The next target of mesenchymal stem cell-derived exosomes in the context of ischemic stroke. World J Stem Cells 2023; 15(3): 52-70 |
| URL |
https://www.wjgnet.com/1948-0210/full/v15/i3/52.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v15.i3.52 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
